State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy

Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterised by ventricular arrhythmia and an increased risk of sudden cardiac death (SCD). Numerous genetic determinants and phenotypic manifestations have been discovered in ACM, posing a significant clinical challenge. Further to this, wider evaluation of family members has revealed incomplete penetrance and variable expressivity in ACM, suggesting a complex genotype-phenotype relationship. This review details the genetic basis of ACM with specific genotype-phenotype associations, providing the reader with a nuanced perspective of this condition; whilst also proposing a future roadmap to delivering precision medicine-based management in ACM.

[1]  F. Ruschitzka,et al.  Familial dilated cardiomyopathy associated with a novel heterozygous RYR2 early truncating variant , 2020, Cardiology journal.

[2]  A. Mazzanti,et al.  Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. , 2020, International journal of cardiology.

[3]  P. Syrris,et al.  Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype. , 2020, International journal of cardiology.

[4]  X. Wehrens,et al.  Genetic Basis and Molecular Biology of Cardiac Arrhythmias in Cardiomyopathies. , 2020, Cardiovascular research.

[5]  H. Calkins,et al.  The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy. , 2020, European heart journal.

[6]  J. Hollander,et al.  Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.

[7]  S. Iliceto,et al.  Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy , 2020, Circulation.

[8]  D. Corrado,et al.  Natural History of Arrhythmogenic Cardiomyopathy , 2020, Journal of clinical medicine.

[9]  R. Zwart,et al.  Clinical characteristics and determinants of phenotype in TMEM43 Arrhythmogenic right ventricular cardiomyopathy type 5. , 2020, Heart rhythm.

[10]  S. Petersen,et al.  Cardiovascular magnetic resonance imaging volume criteria for arrhythmogenic right ventricular cardiomyopathy: need for update? , 2020, European heart journal.

[11]  D. Corrado,et al.  Right ventricular dilatation in arrhythmogenic right ventricular cardiomyopathy: need for a revision of the 2010 International Task Force criteria. , 2020, European heart journal.

[12]  J. Denny,et al.  The "All of Us" Research Program. , 2019, The New England journal of medicine.

[13]  M. Link,et al.  2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. , 2019, Heart rhythm.

[14]  D. Judge,et al.  Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy. , 2019, Circulation.

[15]  M. Link,et al.  Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis , 2019, European heart journal.

[16]  E. Kranias,et al.  Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN). , 2019, Circulation research.

[17]  S. Priori,et al.  Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β , 2019, Circulation.

[18]  P. Lambiase,et al.  Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report , 2019, European journal of heart failure.

[19]  R. Porcher,et al.  Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. , 2019, Circulation.

[20]  P. Elliott,et al.  Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study. , 2019, European heart journal cardiovascular Imaging.

[21]  B. Asatryan.  Cardiac Sodium Channel Dysfunction and Dilated Cardiomyopathy: A Contemporary Reappraisal of Pathophysiological Concepts , 2019, Journal of clinical medicine.

[22]  Vassilios J. Bezzerides,et al.  Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents. , 2019, Journal of the American College of Cardiology.

[23]  M. Ashworth,et al.  Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy. , 2019, International Journal of Cardiology.

[24]  G. Condorelli,et al.  The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy , 2019, Nature communications.

[25]  W. Pu,et al.  Molecular mechanisms of arrhythmogenic cardiomyopathy , 2019, Nature Reviews Cardiology.

[26]  L. Mestroni,et al.  Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy , 2019, Circulation research.

[27]  A. Seyhan,et al.  Are innovation and new technologies in precision medicine paving a new era in patients centric care? , 2019, Journal of Translational Medicine.

[28]  J. Mogensen,et al.  Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy , 2019, Circulation: Heart Failure.

[29]  H. Calkins,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy: Progress Toward Personalized Management. , 2019, Annual review of medicine.

[30]  D. Fatkin,et al.  Arrhythmic Genotypes in Familial Dilated Cardiomyopathy: Implications for Genetic Testing and Clinical Management. , 2019, Heart, lung & circulation.

[31]  C. Shenoy,et al.  Desmoplakin Variant-Associated Arrhythmogenic Cardiomyopathy Presenting as Acute Myocarditis. , 2018, Circulation. Genomic and precision medicine.

[32]  L. Steinmetz,et al.  Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy , 2019, Circulation. Heart failure.

[33]  P. Elliott,et al.  Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations. , 2018, Journal of the American College of Cardiology.

[34]  R. Kurzrock,et al.  An avatar for precision cancer therapy , 2018, Nature Biotechnology.

[35]  Anne L. Taylor,et al.  Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals , 2018, JAMA cardiology.

[36]  Silvio C. E. Tosatto,et al.  Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy , 2018, Circulation. Genomic and precision medicine.

[37]  I. van der Made,et al.  RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling , 2018, Circulation.

[38]  J. Healey,et al.  An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis , 2018, European heart journal.

[39]  A. Medeiros-Domingo,et al.  Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies , 2018, Journal of Molecular Medicine.

[40]  D. Gudbjartsson,et al.  Variants in NKX2-5 and FLNC Cause Dilated Cardiomyopathy and Sudden Cardiac Death , 2018, Circulation. Genomic and precision medicine.

[41]  R. Frank,et al.  Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.

[42]  H. Calkins,et al.  Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy , 2018, Journal of the American Heart Association.

[43]  J. Robbins,et al.  Desmin and Cardiac Disease: An Unfolding Story. , 2018, Circulation research.

[44]  Kenneth L. Jones,et al.  Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures , 2018, JACC. Clinical electrophysiology.

[45]  N. A. Najor.  Desmosomes in Human Disease. , 2018, Annual review of pathology.

[46]  Birgit Funke,et al.  Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel , 2018, Genetics in Medicine.

[47]  L. Monserrat,et al.  Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia , 2017, Circulation.

[48]  D. Judge,et al.  Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis , 2017, Cardiovascular research.

[49]  F. Gaita,et al.  Phenotypic expression of ARVC: How 12 lead ECG can predict left or right ventricle involvement. A familiar case series and a review of literature. , 2017, International journal of cardiology.

[50]  Bas van Steensel,et al.  Lamina-Associated Domains: Links with Chromosome Architecture, Heterochromatin, and Gene Repression , 2017, Cell.

[51]  T. Wieland,et al.  Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy , 2017, Circulation. Cardiovascular genetics.

[52]  T. V. van Veen,et al.  Refining the molecular organization of the cardiac intercalated disc , 2017, Cardiovascular research.

[53]  D. Tester,et al.  Whole exome sequencing with genomic triangulation implicates CDH2‐encoded N‐cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy , 2017, Congenital heart disease.

[54]  J. Atherton,et al.  Myofibrillar Cardiomyopathy due to a Novel Desmin Gene Mutation: Complementary Role of Echocardiography, Cardiac Magnetic Resonance, and Genetic Testing in Delineating Diagnosis , 2017, CASE.

[55]  Xiaoshu Cheng,et al.  Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: A systematic review and meta-analysis , 2017, Scientific Reports.

[56]  Dong I. Lee,et al.  Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy. , 2017, Cell reports.

[57]  L. Calò,et al.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.

[58]  M. Horie,et al.  LMNA cardiomyopathy detected in Japanese arrhythmogenic right ventricular cardiomyopathy cohort. , 2016, Journal of cardiology.

[59]  S. Heymans,et al.  Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.

[60]  A. Kleber,et al.  Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy. , 2016, JCI insight.

[61]  D. Panagiotakos,et al.  Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[62]  J. Schwartzentruber,et al.  Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy , 2016, Human Mutation.

[63]  P. Parfrey,et al.  Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy , 2016, Circulation. Arrhythmia and electrophysiology.

[64]  J. Seidman,et al.  Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.

[65]  M. Hadamitzky,et al.  Novel frame-shift mutation in PKP2 associated with arrhythmogenic right ventricular cardiomyopathy: a case report , 2015, BMC Medical Genetics.

[66]  F. Sacher,et al.  Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy , 2015, Circulation. Arrhythmia and electrophysiology.

[67]  M. Link,et al.  Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. , 2015, European heart journal.

[68]  Stefan L. Zimmerman,et al.  Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members , 2015, Circulation. Cardiovascular genetics.

[69]  C. Simone,et al.  Clinical and Functional Characterization of a Novel Mutation in Lamin A/C Gene in a Multigenerational Family with Arrhythmogenic Cardiac Laminopathy , 2015, PloS one.

[70]  M. J. Oliva-Sandoval,et al.  Genetics of myocarditis in arrhythmogenic right ventricular dysplasia. , 2015, Heart rhythm.

[71]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[72]  W. Fang,et al.  A novel NKX2-5 loss-of-function mutation predisposes to familial dilated cardiomyopathy and arrhythmias. , 2015, International journal of molecular medicine.

[73]  S. Russell,et al.  Exercise has a Disproportionate Role in the Pathogenesis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in Patients Without Desmosomal Mutations , 2014, Journal of the American Heart Association.

[74]  L. Mestroni,et al.  Decreased Levels of BAG3 in a Family With a Rare Variant and in Idiopathic Dilated Cardiomyopathy , 2014, Journal of cellular physiology.

[75]  C. Ackerley,et al.  TMEM43 Mutation p.S358L Alters Intercalated Disc Protein Expression and Reduces Conduction Velocity in Arrhythmogenic Right Ventricular Cardiomyopathy , 2014, PloS one.

[76]  L. Mestroni,et al.  Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy , 2014, Journal of Medical Genetics.

[77]  V. Fuster,et al.  The MOGE(S) classification of cardiomyopathy for clinicians. , 2014, Journal of the American College of Cardiology.

[78]  G. Religa,et al.  The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation , 2014, Journal of Translational Medicine.

[79]  Nicole M. Johnson,et al.  Novel and Highly Lethal NKX2.5 Missense Mutation in a Family With Sudden Death and Ventricular Arrhythmia , 2014, Pediatric Cardiology.

[80]  M. Delmar,et al.  Arrhythmogenic cardiomyopathy and Brugada syndrome: Diseases of the connexome , 2014, FEBS letters.

[81]  J. Svendsen,et al.  The Novel Desmin Mutant p.A120D Impairs Filament Formation, Prevents Intercalated Disk Localization, and Causes Sudden Cardiac Death , 2013, Circulation. Cardiovascular genetics.

[82]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[83]  S. Scherer,et al.  TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations , 2013, Human Genetics.

[84]  Ping Liu,et al.  A novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females , 2013, Molecular and Cellular Biochemistry.

[85]  S. Mavrogeni,et al.  Naxos disease evolution mimicking acute myocarditis: the role of cardiovascular magnetic resonance imaging. , 2013, International journal of cardiology.

[86]  J. Towbin,et al.  Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. , 2013, Journal of the American College of Cardiology.

[87]  P. Elliott,et al.  Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada. , 2013, European heart journal.

[88]  Paco Hulpiau,et al.  Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. , 2013, European heart journal.

[89]  R. Hauer,et al.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. , 2015, European heart journal.

[90]  R. Hauer,et al.  Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.

[91]  N. Baikoussis,et al.  The cytoskeleton of the cardiac muscle cell. , 2012, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[92]  P. Vardas,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia and troponin release. Myocarditis or the "hot phase" of the disease? , 2012, International journal of cardiology.

[93]  M. Ashworth,et al.  Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. , 2012, European heart journal.

[94]  D. Jenne,et al.  Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7 is caused by a DES mutation , 2012, European Journal of Human Genetics.

[95]  杜昕,et al.  Inherited cardiomyopathies , 2012 .

[96]  L. Mestroni,et al.  Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.

[97]  F. van Roy,et al.  Loss of αT-catenin alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy and ventricular arrhythmia following acute ischemia , 2012, Journal of Cell Science.

[98]  S. Mavrogeni,et al.  Cardiac magnetic resonance can early assess the presence and severity of heart involvement in Naxos disease. , 2012, International journal of cardiology.

[99]  T. Arimura,et al.  Dilated cardiomyopathy‐associated BAG3 mutations impair Z‐disc assembly and enhance sensitivity to apoptosis in cardiomyocytes , 2011, Human mutation.

[100]  Elizabeth R. Duffy,et al.  Altered Desmosomal Proteins in Granulomatous Myocarditis and Potential Pathogenic Links to Arrhythmogenic Right Ventricular Cardiomyopathy , 2011, Circulation. Arrhythmia and electrophysiology.

[101]  Brian R. Anderson,et al.  Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes , 2011, Circulation.

[102]  L. Jordaens,et al.  Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study , 2011, Circulation.

[103]  J. Caldwell,et al.  SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. , 2011, Journal of the American College of Cardiology.

[104]  L. Mestroni,et al.  Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. , 2011, European heart journal.

[105]  Deborah A Nickerson,et al.  Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. , 2011, American journal of human genetics.

[106]  C. Antzelevitch,et al.  Overview of Basic Mechanisms of Cardiac Arrhythmia. , 2011, Cardiac electrophysiology clinics.

[107]  M. Vorgerd,et al.  De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. , 2010, Human molecular genetics.

[108]  J. Borlak,et al.  NKX2–5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD) , 2010, Human mutation.

[109]  W. McKenna,et al.  The Cardiac Desmosome and Arrhythmogenic Cardiomyopathies: From Gene to Disease , 2010, Circulation research.

[110]  W. Roberts,et al.  Some previously neglected examples of arrhythmogenic right ventricular dysplasia/cardiomyopathy and frequency of its various reported manifestations. , 2010, The American journal of cardiology.

[111]  H. Tan,et al.  Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[112]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[113]  K. Bötzel,et al.  Divergent Molecular Effects of Desmin Mutations on Protein Assembly in Myofibrillar Myopathy , 2010, Journal of Neuropathology and Experimental Neurology.

[114]  I. V. Van Gelder,et al.  Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. , 2009, Heart rhythm.

[115]  P. Pellikka,et al.  Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[116]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2009, The Lancet.

[117]  Dudley J Pennell,et al.  Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.

[118]  B. Wintersperger,et al.  Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies , 2008, Neuromuscular Disorders.

[119]  Sean Connors,et al.  Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.

[120]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[121]  A. Wilde,et al.  Expanding Spectrum of Human RYR2-Related Disease: New Electrocardiographic, Structural, and Genetic Features , 2007, Circulation.

[122]  F. Braet,et al.  A unique and specific interaction between αT-catenin and plakophilin-2 in the area composita, the mixed-type junctional structure of cardiac intercalated discs , 2007, Journal of Cell Science.

[123]  Wei Zhang,et al.  Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy , 2006, Proceedings of the National Academy of Sciences.

[124]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[125]  Gian Antonio Danieli,et al.  Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. , 2005, Cardiovascular Research.

[126]  D. Paulin,et al.  Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. , 2004, Experimental cell research.

[127]  N. Protonotarios,et al.  Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[128]  Siegfried Labeit,et al.  The giant protein titin: a major player in myocardial mechanics, signaling, and disease. , 2004, Circulation research.

[129]  S. Rosenheck,et al.  Arrhythmogenic Right Ventricular Dysplasia A Recessive Mutation in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia, Skin Disorder, and Woolly Hair , 2003 .

[130]  M. Michalodimitrakis,et al.  Left Side Right Ventricular Cardiomyopathy , 2002, Medicine, science, and the law.

[131]  D. Bers.  Cardiac excitation–contraction coupling , 2002, Nature.

[132]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[133]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[134]  A. Starzinski-Powitz,et al.  The armadillo repeat region targets ARVCF to cadherin-based cellular junctions. , 2000, Journal of cell science.

[135]  D. Kelsell,et al.  Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. , 2000, Human molecular genetics.

[136]  A. Crosby,et al.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[137]  J. Seidman,et al.  Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. , 1999, The Journal of clinical investigation.

[138]  A. Feldman,et al.  The human phospholamban gene: structure and expression. , 1999, Journal of molecular and cellular cardiology.

[139]  L. Carvajal-Huerta.  Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. , 1998, Journal of the American Academy of Dermatology.

[140]  W. Mckenna,et al.  Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. , 1998, Circulation.

[141]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[142]  G Thiene,et al.  The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. , 1994, Human molecular genetics.

[143]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[144]  S. Olsson,et al.  Arrhythmogenic right ventricular dysplasia in brother and sister: Is it related to myocarditis? , 1990, Pediatric Cardiology.

[145]  J. Wrana,et al.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. , 1989, The Journal of biological chemistry.

[146]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[147]  N. Protonotarios,et al.  Cardiac abnormalities in familial palmoplantar keratosis. , 1986, British heart journal.

[148]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.

[149]  C. Kawai,et al.  Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. , 1980, British heart journal.

[150]  W. Brigden.  Uncommon myocardial diseases; the non-coronary cardiomyopathies. , 1957, Lancet.

[151]  Daowen Wang,et al.  Distal myopathy induced arrhythmogenic right ventricular cardiomyopathy in a pedigree carrying novel DSG2 null variant. , 2019, International journal of cardiology.

[152]  R. N. Planken,et al.  Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging , 2019, European heart journal cardiovascular Imaging.

[153]  P. Syrris,et al.  Prevalence of 18 F-Fluorodeoxyglucose Positron Emission Tomography Abnormalities in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy , 2018 .

[154]  R. Hauer,et al.  Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis , 2017, Cardiovascular research.

[155]  S. Rizzo,et al.  Arrhythmogenic Cardiomyopathy: History and Pathology , 2016 .

[156]  H. Calkins.  Arrhythmogenic right ventricular dysplasia. , 2013, Current problems in cardiology.

[157]  M. Vorgerd,et al.  Filamin C-related myopathies: pathology and mechanisms , 2012, Acta Neuropathologica.

[158]  Shailesh V. Date.  The Rosetta stone method. , 2008, Methods in molecular biology.